Skip to main content
Equibles

WINDLAS · Windlas Biotech Limited · Financials

Use WINDLAS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research WINDLAS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
1,001.45 INR -11.75 (-1.16%) At close · Nov 13
Rebalance outlook locked
Market Cap
20.67B INR
Shares
20.64M
Volume · Nov 13 70.29K Avg daily vol (3M) 148.05K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
9.04B +19%
FY2026 Revenue FY2022–FY2026
Net Income
664.35M +9.5%
FY2026 Net Income FY2022–FY2026
Operating Cash Flow
1.05B +53.8%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022
INR 9.84B 9.04B 7.6B 6.31B 5.13B 4.66B
INR 304.96M 307.43M 279.85M 134.44M 123.64M 121.47M
INR 67.36M 48.25M 43.82M 11.03M 7.86M 14.17M
INR 863.21M 869.31M 793.94M 770.23M 570.57M 460.37M
INR 196.46M 204.96M 187.45M 188.79M 144.13M 74.76M
INR 666.75M 664.35M 606.49M 581.44M 426.44M 385.61M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 395.8M in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.